Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare
Avalo Therapeutics Inc. Long Term Debt 2015–2025
Avalo Therapeutics Inc. annual/quarterly long term debt history from 2015 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Avalo Therapeutics Inc. long term debt for the quarter ending December 31, 2018 were 14.3M, a 508.80% increase year-over-year.
- Avalo Therapeutics Inc. long term debt for 2018 were 14.3M, a 508.80% increase from 2015.
- Avalo Therapeutics Inc. long term debt for 2015 were 2.4M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Avalo Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $14 |
| 2015 | $2 |
| Avalo Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2018-12-31 | $14 |
| 2015-12-31 | $2 |
Avalo Therapeutics Inc. Long Term Debt — FAQ
Avalo Therapeutics Inc. (AVTX) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTX's long term debt history?
The chart and table above show Avalo Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.